Progressive strength training to prevent LYmphoedema in the first year after breast CAncer - the LYCA feasibility study.
Identifieur interne : 008C09 ( Ncbi/Merge ); précédent : 008C08; suivant : 008C10Progressive strength training to prevent LYmphoedema in the first year after breast CAncer - the LYCA feasibility study.
Auteurs : Gunn Ammitzb Ll [Danemark] ; Charlotte Lanng [Danemark] ; Niels Kroman [Danemark] ; Bo Zerahn [Danemark] ; Ole Hyldegaard [Danemark] ; Klaus Kaae Andersen [Danemark] ; Christoffer Johansen [Danemark] ; Susanne Oksbjerg Dalton [Danemark]Source :
- Acta oncologica (Stockholm, Sweden) [ 1651-226X ] ; 2017.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- physiopathology : Breast Neoplasms.
- prevention & control : Breast Cancer Lymphedema.
- surgery : Breast Neoplasms.
- Aged, Body Composition, Feasibility Studies, Female, Humans, Middle Aged, Muscle Strength, Pilot Projects, Prospective Studies, Resistance Training.
Abstract
Lymphoedema is a common late effect after breast cancer (BC) that has no effective cure once chronic. Accumulating evidence supports progressive strength training (PRT) as a safe exercise modality in relation to the onset and exacerbation of lymphoedema. In the 'preventive intervention against LYmphoedema after breast CAncer' (LYCA) feasibility study we examined the feasibility of a program of PRT in the first year after BC to inform a planned randomised controlled trial (RCT).
DOI: 10.1080/0284186X.2016.1268266
PubMed: 28084150
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000416
- to stream PubMed, to step Curation: 000416
- to stream PubMed, to step Checkpoint: 000416
Links to Exploration step
pubmed:28084150Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Progressive strength training to prevent LYmphoedema in the first year after breast CAncer - the LYCA feasibility study.</title><author><name sortKey="Ammitzb Ll, Gunn" sort="Ammitzb Ll, Gunn" uniqKey="Ammitzb Ll G" first="Gunn" last="Ammitzb Ll">Gunn Ammitzb Ll</name><affiliation wicri:level="1"><nlm:affiliation>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen </wicri:regionArea><wicri:noRegion>Copenhagen </wicri:noRegion></affiliation></author><author><name sortKey="Lanng, Charlotte" sort="Lanng, Charlotte" uniqKey="Lanng C" first="Charlotte" last="Lanng">Charlotte Lanng</name><affiliation wicri:level="1"><nlm:affiliation>b Department of Breast Surgery , Herlev University Hospital , Herlev , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>b Department of Breast Surgery , Herlev University Hospital , Herlev </wicri:regionArea><wicri:noRegion>Herlev </wicri:noRegion></affiliation></author><author><name sortKey="Kroman, Niels" sort="Kroman, Niels" uniqKey="Kroman N" first="Niels" last="Kroman">Niels Kroman</name><affiliation wicri:level="1"><nlm:affiliation>c Section for Breast Surgery, Department of Plastic Surgery, Breast Surgery and Burns , Rigshospitalet , Copenhagen , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>c Section for Breast Surgery, Department of Plastic Surgery, Breast Surgery and Burns , Rigshospitalet , Copenhagen </wicri:regionArea><wicri:noRegion>Copenhagen </wicri:noRegion></affiliation></author><author><name sortKey="Zerahn, Bo" sort="Zerahn, Bo" uniqKey="Zerahn B" first="Bo" last="Zerahn">Bo Zerahn</name><affiliation wicri:level="1"><nlm:affiliation>d Department of Clinical Physiology and Nuclear Medicine , Herlev University Hospital , Herlev , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>d Department of Clinical Physiology and Nuclear Medicine , Herlev University Hospital , Herlev </wicri:regionArea><wicri:noRegion>Herlev </wicri:noRegion></affiliation></author><author><name sortKey="Hyldegaard, Ole" sort="Hyldegaard, Ole" uniqKey="Hyldegaard O" first="Ole" last="Hyldegaard">Ole Hyldegaard</name><affiliation wicri:level="1"><nlm:affiliation>e Section for Hyperbaric Oxygen Treatment, Department for Anaesthetics and Operations , Rigshospitalet , Copenhagen , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>e Section for Hyperbaric Oxygen Treatment, Department for Anaesthetics and Operations , Rigshospitalet , Copenhagen </wicri:regionArea><wicri:noRegion>Copenhagen </wicri:noRegion></affiliation></author><author><name sortKey="Kaae Andersen, Klaus" sort="Kaae Andersen, Klaus" uniqKey="Kaae Andersen K" first="Klaus" last="Kaae Andersen">Klaus Kaae Andersen</name><affiliation wicri:level="1"><nlm:affiliation>f Unit of Statistics, Bioinformatics and Registry , Danish Cancer Society Research Center , Copenhagen , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>f Unit of Statistics, Bioinformatics and Registry , Danish Cancer Society Research Center , Copenhagen </wicri:regionArea><wicri:noRegion>Copenhagen </wicri:noRegion></affiliation></author><author><name sortKey="Johansen, Christoffer" sort="Johansen, Christoffer" uniqKey="Johansen C" first="Christoffer" last="Johansen">Christoffer Johansen</name><affiliation wicri:level="1"><nlm:affiliation>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen </wicri:regionArea><wicri:noRegion>Copenhagen </wicri:noRegion></affiliation></author><author><name sortKey="Dalton, Susanne Oksbjerg" sort="Dalton, Susanne Oksbjerg" uniqKey="Dalton S" first="Susanne Oksbjerg" last="Dalton">Susanne Oksbjerg Dalton</name><affiliation wicri:level="1"><nlm:affiliation>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen </wicri:regionArea><wicri:noRegion>Copenhagen </wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28084150</idno><idno type="pmid">28084150</idno><idno type="doi">10.1080/0284186X.2016.1268266</idno><idno type="wicri:Area/PubMed/Corpus">000416</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000416</idno><idno type="wicri:Area/PubMed/Curation">000416</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000416</idno><idno type="wicri:Area/PubMed/Checkpoint">000416</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000416</idno><idno type="wicri:Area/Ncbi/Merge">008C09</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Progressive strength training to prevent LYmphoedema in the first year after breast CAncer - the LYCA feasibility study.</title><author><name sortKey="Ammitzb Ll, Gunn" sort="Ammitzb Ll, Gunn" uniqKey="Ammitzb Ll G" first="Gunn" last="Ammitzb Ll">Gunn Ammitzb Ll</name><affiliation wicri:level="1"><nlm:affiliation>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen </wicri:regionArea><wicri:noRegion>Copenhagen </wicri:noRegion></affiliation></author><author><name sortKey="Lanng, Charlotte" sort="Lanng, Charlotte" uniqKey="Lanng C" first="Charlotte" last="Lanng">Charlotte Lanng</name><affiliation wicri:level="1"><nlm:affiliation>b Department of Breast Surgery , Herlev University Hospital , Herlev , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>b Department of Breast Surgery , Herlev University Hospital , Herlev </wicri:regionArea><wicri:noRegion>Herlev </wicri:noRegion></affiliation></author><author><name sortKey="Kroman, Niels" sort="Kroman, Niels" uniqKey="Kroman N" first="Niels" last="Kroman">Niels Kroman</name><affiliation wicri:level="1"><nlm:affiliation>c Section for Breast Surgery, Department of Plastic Surgery, Breast Surgery and Burns , Rigshospitalet , Copenhagen , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>c Section for Breast Surgery, Department of Plastic Surgery, Breast Surgery and Burns , Rigshospitalet , Copenhagen </wicri:regionArea><wicri:noRegion>Copenhagen </wicri:noRegion></affiliation></author><author><name sortKey="Zerahn, Bo" sort="Zerahn, Bo" uniqKey="Zerahn B" first="Bo" last="Zerahn">Bo Zerahn</name><affiliation wicri:level="1"><nlm:affiliation>d Department of Clinical Physiology and Nuclear Medicine , Herlev University Hospital , Herlev , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>d Department of Clinical Physiology and Nuclear Medicine , Herlev University Hospital , Herlev </wicri:regionArea><wicri:noRegion>Herlev </wicri:noRegion></affiliation></author><author><name sortKey="Hyldegaard, Ole" sort="Hyldegaard, Ole" uniqKey="Hyldegaard O" first="Ole" last="Hyldegaard">Ole Hyldegaard</name><affiliation wicri:level="1"><nlm:affiliation>e Section for Hyperbaric Oxygen Treatment, Department for Anaesthetics and Operations , Rigshospitalet , Copenhagen , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>e Section for Hyperbaric Oxygen Treatment, Department for Anaesthetics and Operations , Rigshospitalet , Copenhagen </wicri:regionArea><wicri:noRegion>Copenhagen </wicri:noRegion></affiliation></author><author><name sortKey="Kaae Andersen, Klaus" sort="Kaae Andersen, Klaus" uniqKey="Kaae Andersen K" first="Klaus" last="Kaae Andersen">Klaus Kaae Andersen</name><affiliation wicri:level="1"><nlm:affiliation>f Unit of Statistics, Bioinformatics and Registry , Danish Cancer Society Research Center , Copenhagen , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>f Unit of Statistics, Bioinformatics and Registry , Danish Cancer Society Research Center , Copenhagen </wicri:regionArea><wicri:noRegion>Copenhagen </wicri:noRegion></affiliation></author><author><name sortKey="Johansen, Christoffer" sort="Johansen, Christoffer" uniqKey="Johansen C" first="Christoffer" last="Johansen">Christoffer Johansen</name><affiliation wicri:level="1"><nlm:affiliation>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen </wicri:regionArea><wicri:noRegion>Copenhagen </wicri:noRegion></affiliation></author><author><name sortKey="Dalton, Susanne Oksbjerg" sort="Dalton, Susanne Oksbjerg" uniqKey="Dalton S" first="Susanne Oksbjerg" last="Dalton">Susanne Oksbjerg Dalton</name><affiliation wicri:level="1"><nlm:affiliation>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen </wicri:regionArea><wicri:noRegion>Copenhagen </wicri:noRegion></affiliation></author></analytic><series><title level="j">Acta oncologica (Stockholm, Sweden)</title><idno type="eISSN">1651-226X</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Body Composition</term><term>Breast Cancer Lymphedema (prevention & control)</term><term>Breast Neoplasms (physiopathology)</term><term>Breast Neoplasms (surgery)</term><term>Feasibility Studies</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Muscle Strength</term><term>Pilot Projects</term><term>Prospective Studies</term><term>Resistance Training</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Composition corporelle</term><term>Entraînement en résistance</term><term>Femelle</term><term>Force musculaire</term><term>Humains</term><term>Lymphoedème après cancer du sein ()</term><term>Projets pilotes</term><term>Sujet âgé</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (physiopathologie)</term><term>Études de faisabilité</term><term>Études prospectives</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Breast Cancer Lymphedema</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Body Composition</term><term>Feasibility Studies</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Muscle Strength</term><term>Pilot Projects</term><term>Prospective Studies</term><term>Resistance Training</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Composition corporelle</term><term>Entraînement en résistance</term><term>Femelle</term><term>Force musculaire</term><term>Humains</term><term>Lymphoedème après cancer du sein</term><term>Projets pilotes</term><term>Sujet âgé</term><term>Tumeurs du sein</term><term>Études de faisabilité</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphoedema is a common late effect after breast cancer (BC) that has no effective cure once chronic. Accumulating evidence supports progressive strength training (PRT) as a safe exercise modality in relation to the onset and exacerbation of lymphoedema. In the 'preventive intervention against LYmphoedema after breast CAncer' (LYCA) feasibility study we examined the feasibility of a program of PRT in the first year after BC to inform a planned randomised controlled trial (RCT).</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28084150</PMID><DateCreated><Year>2017</Year><Month>01</Month><Day>13</Day></DateCreated><DateCompleted><Year>2017</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2017</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1651-226X</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Acta oncologica (Stockholm, Sweden)</Title><ISOAbbreviation>Acta Oncol</ISOAbbreviation></Journal><ArticleTitle>Progressive strength training to prevent LYmphoedema in the first year after breast CAncer - the LYCA feasibility study.</ArticleTitle><Pagination><MedlinePgn>360-366</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/0284186X.2016.1268266</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lymphoedema is a common late effect after breast cancer (BC) that has no effective cure once chronic. Accumulating evidence supports progressive strength training (PRT) as a safe exercise modality in relation to the onset and exacerbation of lymphoedema. In the 'preventive intervention against LYmphoedema after breast CAncer' (LYCA) feasibility study we examined the feasibility of a program of PRT in the first year after BC to inform a planned randomised controlled trial (RCT).</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">LYCA was a one-group prospective pilot trial inviting women operated with axillary lymph node dissection for unilateral primary BC. Participants exercised three times a week for 50 weeks (20 weeks supervised followed by 30 weeks home-based exercise). The program ensured slow individualised progression during the exercise program. The primary outcome was feasibility measured by eligibility and recruitment rates, as well as questionnaire-assessed satisfaction and adherence to exercise. Furthermore, we assessed arm interlimb volume difference by water displacement, muscle strength by dynamic and isometric muscle testing and range of movement in the shoulder by goniometry.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In August 2015, eight of 11 eligible patients accepted participation. Two of them dropped out early due to other health issues. The remaining six participants had high exercise adherence through the supervised period, but only three maintained this through the home exercise period. Program satisfaction was high and no serious adverse events from testing or exercising were reported. One participant presented with lymphoedema at 50-week follow-up. Muscle strength markedly increased with supervised exercise, but was not fully maintained through the home exercise period. Range of shoulder movement was not negatively affected by the program.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Recruitment, testing, and exercise in LYCA was safe and feasible. At the 50-week follow-up, there was one case of lymphoedema. The LYCA program will be further tested in a full-scale RCT.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ammitzbøll</LastName><ForeName>Gunn</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen , Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanng</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>b Department of Breast Surgery , Herlev University Hospital , Herlev , Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kroman</LastName><ForeName>Niels</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>c Section for Breast Surgery, Department of Plastic Surgery, Breast Surgery and Burns , Rigshospitalet , Copenhagen , Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zerahn</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>d Department of Clinical Physiology and Nuclear Medicine , Herlev University Hospital , Herlev , Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyldegaard</LastName><ForeName>Ole</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>e Section for Hyperbaric Oxygen Treatment, Department for Anaesthetics and Operations , Rigshospitalet , Copenhagen , Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaae Andersen</LastName><ForeName>Klaus</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>f Unit of Statistics, Bioinformatics and Registry , Danish Cancer Society Research Center , Copenhagen , Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansen</LastName><ForeName>Christoffer</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen , Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>g Oncology Clinic, Finsen Centre , Rigshospitalet , Copenhagen , Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalton</LastName><ForeName>Susanne Oksbjerg</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>a Survivorship Unit , Danish Cancer Society Research Center , Copenhagen , Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Oncol</MedlineTA><NlmUniqueID>8709065</NlmUniqueID><ISSNLinking>0284-186X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001823" MajorTopicYN="N">Body Composition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072656" MajorTopicYN="N">Breast Cancer Lymphedema</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055070" MajorTopicYN="Y">Resistance Training</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28084150</ArticleId><ArticleId IdType="doi">10.1080/0284186X.2016.1268266</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Danemark</li></country></list><tree><country name="Danemark"><noRegion><name sortKey="Ammitzb Ll, Gunn" sort="Ammitzb Ll, Gunn" uniqKey="Ammitzb Ll G" first="Gunn" last="Ammitzb Ll">Gunn Ammitzb Ll</name></noRegion><name sortKey="Dalton, Susanne Oksbjerg" sort="Dalton, Susanne Oksbjerg" uniqKey="Dalton S" first="Susanne Oksbjerg" last="Dalton">Susanne Oksbjerg Dalton</name><name sortKey="Hyldegaard, Ole" sort="Hyldegaard, Ole" uniqKey="Hyldegaard O" first="Ole" last="Hyldegaard">Ole Hyldegaard</name><name sortKey="Johansen, Christoffer" sort="Johansen, Christoffer" uniqKey="Johansen C" first="Christoffer" last="Johansen">Christoffer Johansen</name><name sortKey="Kaae Andersen, Klaus" sort="Kaae Andersen, Klaus" uniqKey="Kaae Andersen K" first="Klaus" last="Kaae Andersen">Klaus Kaae Andersen</name><name sortKey="Kroman, Niels" sort="Kroman, Niels" uniqKey="Kroman N" first="Niels" last="Kroman">Niels Kroman</name><name sortKey="Lanng, Charlotte" sort="Lanng, Charlotte" uniqKey="Lanng C" first="Charlotte" last="Lanng">Charlotte Lanng</name><name sortKey="Zerahn, Bo" sort="Zerahn, Bo" uniqKey="Zerahn B" first="Bo" last="Zerahn">Bo Zerahn</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008C09 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 008C09 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:28084150
|texte= Progressive strength training to prevent LYmphoedema in the first year after breast CAncer - the LYCA feasibility study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:28084150" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |